These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 7661582

  • 1. Salvage chemotherapy with PEM and long-CF regimen in CDDP refractory advanced head and neck cancer.
    Kohno N, Ichikawa G, Shirasaka T, Inuyama Y, Kawaida M, Ohnuma T.
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():209-14. PubMed ID: 7661582
    [Abstract] [Full Text] [Related]

  • 2. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
    Kohno N, Kitahara S, Tamura E, Tanabe T, Nakanoboh M, Kawada M, Shirasaka T.
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
    [Abstract] [Full Text] [Related]

  • 3. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
    Fujii M, Ohno Y, Tokumaru Y, Imanishi Y, Kanke M.
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
    [Abstract] [Full Text] [Related]

  • 4. [Low-dose CDDP and 5-FU for head and neck cancer patients].
    Fujii M, Kanke M, Tomita T.
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1542-7. PubMed ID: 10553410
    [Abstract] [Full Text] [Related]

  • 5. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H, Tsukuda M, Taguchi T.
    Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
    [Abstract] [Full Text] [Related]

  • 6. [Clinical effects and toxicity of chemotherapy with cisplatin for head and neck cancer--the multi-institutional joint research in Tokai district].
    Tohnai I, Kawabe Y, Nakashima T, Yamagiwa M, Suzuki T, Mizuno A, Mineda H.
    Nihon Gan Chiryo Gakkai Shi; 1990 Oct 20; 25(10):2567-78. PubMed ID: 1702133
    [Abstract] [Full Text] [Related]

  • 7. [Multi-institutional cooperative study on combination chemotherapy with THP, CDDP and 5-FU for squamous cell carcinoma of the head and neck].
    Urade M, Yanagisawa T, Kishimoto H, Yoshioka W, Teranobu O, Shigeta Y, Komori T, Shimada K, Ohnishi M, Tanaka Y, Kamiya Y, Akazawa N, Oko T, Takahashi N, Adachi R, Tanigaki S, Hirata Y, Yakushiji N, Kitamura R, Hashikawa N, Hyogo Oncology Group for Oromaxillary Tumors.
    Gan To Kagaku Ryoho; 2001 Jun 20; 28(6):789-95. PubMed ID: 11432346
    [Abstract] [Full Text] [Related]

  • 8. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC, Fabian RL.
    Laryngoscope; 1992 Aug 20; 102(8):901-6. PubMed ID: 1379664
    [Abstract] [Full Text] [Related]

  • 9. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Aug 20; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 10. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA, Dimery IW, Lee JJ, Perez C, Hong WK, Lippman SM.
    Cancer J Sci Am; 1997 Aug 20; 3(2):92-9. PubMed ID: 9099459
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A randomized trial between two neoadjuvant chemotherapy protocols: CDDP + 5-FU versus CDDP + VP16 in advanced cancer of the head and neck.
    Prévost A, Mérol JC, Aimé P, Moutel K, Roger-Liautaud F, Nasca S, Legros M, Coninx P.
    Oncol Rep; 2005 Sep 20; 14(3):771-6. PubMed ID: 16077990
    [Abstract] [Full Text] [Related]

  • 13. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martí JL, Lobo F, Pastor P, Valentí V, Belón J, Sánchez MA, Chaib C, Pallarés C, Antón A, Cervantes A, Paz-Ares L, Cortés-Funes H.
    J Clin Oncol; 2005 Dec 01; 23(34):8636-45. PubMed ID: 16275937
    [Abstract] [Full Text] [Related]

  • 14. Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study.
    Schena M, Barone C, Birocco N, Dongiovanni D, Numico G, Colantonio I, Bertetto O.
    Cancer Chemother Pharmacol; 2005 Mar 01; 55(3):271-6. PubMed ID: 15592837
    [Abstract] [Full Text] [Related]

  • 15. [Head and neck cancer].
    Inuyama Y, Fukuda S, Fujii M, Tanaka K, Kawaura M, Kawasaki K, Kohno N.
    Gan To Kagaku Ryoho; 1996 Aug 01; 23(9):1136-42. PubMed ID: 8751800
    [Abstract] [Full Text] [Related]

  • 16. Phase II study of mitomycin C, cisplatin and 5-fluorouracil for advanced and recurrent gastric cancer.
    Kikuyama S, Inada T, Oyama R, Ogata Y.
    Anticancer Res; 2002 Aug 01; 22(6B):3633-6. PubMed ID: 12552968
    [Abstract] [Full Text] [Related]

  • 17. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].
    Tahara M.
    Gan To Kagaku Ryoho; 2006 Jun 01; 33 Suppl 1():167-71. PubMed ID: 16897996
    [Abstract] [Full Text] [Related]

  • 18. Mitomycin C, cisplatin, and 5-fluorouracil for advanced and/or recurrent head and neck squamous cell carcinomas.
    Iop A, Cartei G, Vigevani E, Clocchiatti L, Mansutti M, Sibau AM.
    Am J Clin Oncol; 1997 Oct 01; 20(5):515-8. PubMed ID: 9345340
    [Abstract] [Full Text] [Related]

  • 19. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
    Worden FP, Moon J, Samlowski W, Clark JI, Dakhil SR, Williamson S, Urba SG, Ensley J, Hussain MH, Southwest Oncology Group, Head and Neck Working Group.
    Cancer; 2006 Jul 15; 107(2):319-27. PubMed ID: 16779801
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL, Yeh KH, Lin JT, Hsu C, Liu MY.
    Anticancer Res; 1998 Jul 15; 18(2B):1267-72. PubMed ID: 9615799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.